ay Wei founded Optovue, Inc., in 2003 to develop the next generation of Ophthalmic OCT instruments. His vision in the clinical use of OCT technology has resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, RTVue®. Jay has been working in ophthalmic instrument development and management since 1992, and he has pioneered the commercialization of optical coherence technology for ophthalmic diagnosis since 1994. Prior to founding Optovue, Jay was a Director of Advanced Development and an OCT Program Manager at Carl Zeiss Meditec (Humphrey Instruments). He led the OCT development from ground zero in 1993 and delivered all prior generations of OCT products to the market. Jay received his Bachelor of Science in Electro-physics from the National Chiao-Tung University in Taiwan, and a Master of Science in Applied Optics from the University of New Mexico. He has been granted over 30 patents in ophthalmic devices and has published research in over 10 peer-reviewed journals.

 Ophthalmic innovations